Learning is life

The European Union is preparing for the most significant change in pharmaceutical regulation in over 20 years. On December 11, 2025, political agreement was reached on a new set of rules that will reshape how medicines for human use are developed, approved, and monitored across the EU. The final texts of a new regulation and directive were published in March 2026, marking a major overhaul of the EU pharma legislation framework. This update affects every stage of a medicine’s lifecycle, from...

In pharmaceutical manufacturing, maintaining the accuracy and reliability of data is not just a regulatory requirement - it is a cornerstone of patient safety and product quality. I have seen firsthand how lapses in data integrity can lead to costly recalls, regulatory actions, and most importantly, risks to public health. That is why I want to share practical insights on how to ensure pharmaceutical data integrity throughout the manufacturing process.Data integrity means that all data generated

Explore 2026's critical pharma manufacturing trends: Annex 1 compliance, FDA data integrity, advanced aseptic processing for injectables & biosimilars...